CureLight Medical Diode Laser Systems (S3-BF45);CureLight Medical Diode Laser Systems (S2-B30);CureLight Medical Diode Laser Systems (S3-BF30);CureLight Medical Diode Laser Systems (S2-F15);CureLight Medical Diode Laser Systems (S2-H7.5)
Wuhan Phomed Technology Co., Ltd. · Decision date Oct 8, 2026
What did the FDA decide?
FDA recorded a substantially equivalent decision for K262346 on 2026-10-08, covering the CureLight Medical Diode Laser Systems under five model designations: S3-BF45, S2-B30, S3-BF30, S2-F15 and S2-H7.5. The applicant is Wuhan Phomed Technology Co., Ltd. of Wuhan, China. The submission is a traditional 510(k) filed under regulation 878.4810, product code GEX, in the General & Plastic Surgery specialty, and the public record lists the device classification as Powered Laser Surgical Instrument.
Substantially equivalent means FDA cleared the submission as a 510(k); it is not a premarket approval of the device. The record shows the application was received on 07/10/2026 and decided on 10/08/2026, and that it was not reviewed by a third party, was not a combination product, and had no authorized predetermined change control plan. The record does not state which predicate device was used, what testing supported equivalence, or what indications the cleared systems carry; those details would sit in the underlying 510(k) documents rather than this summary page.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Oct 8, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262346
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Wuhan Phomed Technology Co., Ltd.
- Product code
- GEX
- Decision code
- SESE
- Decision date
- Oct 8, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Powered Laser Surgical Instrument.
- Applicant
- Wuhan Phomed Technology Co., Ltd.
- Product code
- GEX
- FDA device class
- 2
FDA decision timeline
K262346 received
Application receipt date recorded by FDA.
K262346 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code GEX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Single Use Optical FiberK262886 | Quanta System Spa | 510(k) clearance | Nov 5, 2026 | FDA |
| Borze, Inc. | 510(k) clearance | Oct 30, 2026 | FDA | |
| Risu Medical Technology Co., Ltd. | 510(k) clearance | Oct 27, 2026 | FDA | |
| Sanhe PERFECTLASER Technology Co., Ltd. | 510(k) clearance | Oct 26, 2026 | FDA | |
| Beijing Sea Heart International Science and Technologyco.Ltd | 510(k) clearance | Oct 22, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Wuhan Phomed Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Wuhan
Sources and methodology
- Original FDA record: K262346
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


